R, M., E. M. H, E. G, G. A, M. F, E. K. M, M. N, and A. H. M,
"Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.",
Clin Rheumatol, vol. 12, pp. 1373-1380, 2010.
AbstractChronic hepatitis C virus (HCV) viremia has been known to provoke a plethora of autoimmune syndromes referred to as extrahepatic manifestations of chronic HCV infection. Aim of the current study was to assess the prevalence of rheumatologic manifestations among Egyptians with hepatitis C infection and its' association with cryoglobulin profile. The current research represents a cross-sectional study where patients with chronic HCV infection attending the outpatient clinic of the National Hepatology and Tropical Medicine Research Institute over a period of 1 year were interviewed. Patients with decompensated liver disease, on interferon therapy, having end-stage renal disease or coexisting viral infection like hepatitis B surface antibody positive patients were all excluded from the research. Laboratory investigations as well as serological assay including cryoglobulin profile, rheumatoid factor, antinuclear antibody, HCV-PCR were performed. Three hundred and six patients having chronic HCV infection were interviewed in this research. The overall estimated prevalence of rheumatologic manifestations in the current research was 16.39%, chronic fatigue syndrome 9.5%, sicca symptoms 8.8%, arthralgia 6.5%, fibromyalgia 1.9%, myalgia 1.3%, arthritis 0.7%, cryoglobulinemic vasculitis 0.7%, autoimmune hemolytic anemia 0.7%, thrombocytopenia 0.7%. Xerophthalmia was significantly present in male population (p = 0.04), whereas fibromyalgia, cryoglobulinemic vasculitis, arthritis, and autoimmune hemolytic anemia were significantly present in female population under study (p < 0.05). In chronic HCV genotype 4 infection, the prevalence of rheumatologic manifestations was 16.3% with chronic fatigue syndrome and sicca symptoms being the most common with no significant correlation to the degree of elevation of liver disease or viral load.
R, Y., A. - H. MRE, K. M, K. M, and F. A,
"Effect of polymorphisms in IL-12B p40, IL-17A and IL-23 A/G genes on the response of psoriatic patients to narrowband UVB",
Photodermatol Photoimmunol Photomed. , vol. 34, issue 5, pp. 347-349, 2018.
R, F., K. MM, E. W, S. MM, H. A, Z. K, and K. M,
"Single Nucleotide rs760370 Polymorphism at the Main Ribavirin Transporter Gene Detection by PCR-RFLP Assay Compared with the TaqMan Assay and Its Relation to Sustained Virological Response in Chronic HCV Patients Treated with Pegylated Interferon-Ribaviri",
J Interferon Cytokine Res. 2017 Feb;37(2):90-96, vol. 37, issue 2, pp. 90-96, 2017.
R, E. R., Aboueldahab M, Tallima H, Salah M, Mahana N, Fawzi S, Mohamed SH, and F. OM.,
"In Vitro and In Vivo Activities of Arachidonic Acid against Schistosoma mansoni and Schistosoma haematobium.",
Antimicrob Agents Chemother., , vol. 54, issue (8):, pp. 3383-3389, 2010.
R, E., J. JE, R. A, A. H, O. S, K. MM, M. Z, H. J, and S. AA,
"Potential Antimicrobial Activities of Probiotic Lactobacillus Strains Isolated from Raw Milk",
. J Prob Health. , vol. 4(2):, pp. 138, 2016.
R, S., K. R, P. A, F. W, K. K, W. D, and Jhamandas,
"Short amylin receptor antagonist peptides improve memory deficits in Alzheimer's disease mouse model.",
Sci Rep., vol. 9, issue 1, pp. 10942, 2019.
R, H., M. A, K. DA, S. RA, A. hafez MN, G. LM, H. FM, and undefined,
"Prognostic Role of H3K9 Methyltransferase G9a and Sprouty 1 in Colorectal Carcinoma",
Advances in Oncology Research and Treatments, vol. t 2016, 1:1, 2016.
R, K., H. Y, H. K, and A. K,
"Synthetic graft for reconstruction of middle hepatic vein tributaries in living-donor liver transplant",
Exp Clin Transplant., vol. 13, issue Suppl 1, pp. 318-22, 2015.
R, H., L. W, A. R, and F. A,
"Diagnostic dilemma of cardiac syncope in pediatric patients",
Indian Pacing Electrophysiol J., vol. 8, issue 1, pp. 22-31, 2008.